Skip to search formSkip to main contentSkip to account menu

WAY-151932

Known as: VNA-932 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Benzazepines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Synthesis and characterization of novel azole heterocycles based on 2,5-disubstituted thiadiazole
The development of simple synthetic routes to widely used organic compounds using readily available reagents is one of the main… 
2007
2007
Identification and synthesis of major metabolites of Vasopressin V2-receptor agonist WAY-151932, and antagonist, Lixivaptan.
2002
2002
WAY-VNA-932: Treatment of central diabetes insipidus, treatment of nocturnal enuresis, treatment of nocturia, vasopressin V2 agonist
WAY-VNA-932 is a novel, orally active nonpeptide small molecule which exhibits vasopressin V 2 receptor agonism. In CHO cells… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)